ETFS Holding Amgen Inc

 
ETF Quotes for ETFS Holding Amgen Inc top ^
  • Holdings: Johnson & Johnson , Pfizer Inc , Merck & Co Inc , Gilead Sciences Inc , Amgen Inc ,
  • Morningstar Rating: 3 Stars
Sign-up for iyh investment picks
  • Holdings: Biogen Idec Inc , Celgene Corp , Gilead Sciences Inc , Amgen Inc , Regeneron Pharmaceuticals Inc ,
  • Morningstar Rating: 5 Stars
Sign-up for ibb investment picks
  • Holdings: Johnson & Johnson , Pfizer Inc , Merck & Co Inc , Gilead Sciences Inc , Amgen Inc ,
  • Morningstar Rating: 3 Stars
Sign-up for xlv investment picks
  • Holdings: Gilead Sciences Inc , Amgen Inc , Celgene Corp , Biogen Idec Inc , Biomarin Pharmaceutical Inc ,
  • Morningstar Rating: 5 Stars
Sign-up for bbh investment picks
  • Holdings: Johnson & Johnson , Pfizer Inc , Merck & Co Inc , Gilead Sciences Inc , Amgen Inc ,
  • Morningstar Rating: 3 Stars
Sign-up for vht investment picks

 
Stock Quotes for Amgen Inc top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Large Core
  • Stock Type: Slow Growth
  • Morningstar Rating: 4 Stars
Sign-up for amgn investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Large Core
  • Stock Type: Slow Growth
  • Morningstar Rating: 4 Stars
Sign-up for amgn investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Large Core
  • Stock Type: Speculative Growth
Sign-up for amg%20n investment picks

 
News Articles for Amgen Inc top ^
Amgen Inc. (AMGN) said late Monday that third-quarter net income was $1.24 billion, or $1.61 a share, compared with $1.37 billion, or $1.79 a share, for the same period a year ago.
Sign-up for Amgen net drops, but adjusted earnings beat views investment picks
Third Quarter 2014 GAAP EPS Were $1.61 2014 Total Revenues and Adjusted EPS Guidance Increased to $19.8-$20.0 Billion and $8.45-$8.55, Respectively THOUSAND OAKS, Calif.
Sign-up for Amgen's Third Quarter 2014 Revenues Increased 6 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 19 Percent To $2.30 investment picks
THOUSAND OAKS, Calif.
Sign-up for Amgen To Webcast 2014 Business Review Meeting On October 28 investment picks
THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Webcast of 2014 Third Quarter Financial Results investment picks
THOUSAND OAKS, Calif.
Sign-up for Amgen To Present At The Credit Suisse Annual Healthcare Conference investment picks
Presentations Including Pivotal Data on Kyprolis® and Blinatumomab, a BiTE® Immunotherapy, Demonstrate Company's Continued Commitment to Developing Treatments for Difficult-to-Treat Blood Cancers THOUSAND OAKS, Calif.
Sign-up for Amgen Highlights New Data In The Treatment Of Blood Cancers At ASH 2014 investment picks
Study Failed to Meet Secondary Endpoint of Overall Survival THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Top-Line Secondary Endpoint Results Of Phase 3 Trebananib TRINOVA-1 Trial In Patients With Recurrent Ovarian Cancer investment picks
2014/10/28
Focusing development on rare autoimmune disorder IgG4-related disease (IgG4-RD) Ongoing Phase 1b/2a clinical trial on track to report topline results by end of 2014 Conference call today at 5:00 p.m. EDT MONROVIA, Calif.
Sign-up for Xencor Renegotiates XmAb®5871 Agreement with Amgen; Regains All Rights and Plans Clinical Development in Rare Autoimmune Disease investment picks
Amgen's stock (AMGN) rose 2.4% in premarket trade Tuesday, after the biotechnology company outlined its plans to return capital to shareholders, including resuming share repurchases and raising its dividend, and provided an upbeat profit and sales outlook for 2015.
Sign-up for Amgen's stock rises after company outlines capital allocation plans investment picks
Plans to Payout Approximately 60 Percent of Adjusted Net Income on Average to Shareholders Through 2018 Guides to Improved Adjusted Operating Margin of 52-54 Percent by 2018 Reinitiating Share Repurchases With Plans for Approximately $2 Billion Through 2015 Plans to Increase Dividend 30 Percent Beginning 1Q 2015 Expects to Deliver Double-Digit Adjusted Earnings Per Share (EPS) Growth on Average Through 2018 $1.5 Billion in Annual Savings Planned by 2018 Preparing to Launch Four High-Potential Innovative Medicines in 2015 Expands Biosimilars Portfolio to Nine Programs, Total Portfolio Represents a $3 Billion Plus Opportunity Launching Next-Generation Biomanufacturing Technologies in 2017 Provides Preliminary 2015 Guidance of Revenues of $20.8-$21.3 Billion and Adjusted EPS of $9.05-$9.40 NEW YORK , Oct.
Sign-up for Amgen Outlines Strategy, Growth Objectives And Capital Allocation Plans investment picks
THOUSAND OAKS, Calif.
Sign-up for Amgen To Present At The Jefferies Global Healthcare Conference investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

ETFS Holding Amgen Inc
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding Ametek, Inc.  |  Next: ETFS Holding Amkor Technology Inc